
In this free webinar, explore strategies for strengthening defensibility, transparency and consistency in biopharma decision-making. Attendees will learn why traditional multi-criteria decision analysis scorecards fail in real organizations and how to avoid "spreadsheet theater." The featured speaker will share how structured AI agent workflows can turn messy evidence into consistent, auditable decisions. Attendees will see how to interpret robustness: what drives a ranking and what would flip it. The speaker will also discuss how to run a lightweight pilot and measure impact.
TORONTO, March 9, 2026 /PRNewswire/ -- Biopharma teams routinely face high-stakes prioritization decisions, including which targets to advance, which biomarkers to pursue and which clinical strategies to implement. While data availability continues to increase, many organizations lack a structured, transparent process for translating evidence into consistent and defensible decisions. This webinar examines how a decision-support tool can improve the rigor and clarity of prioritization decisions.
Traditional approaches such as multi-criteria decision analysis and weighted scorecards are widely used but often rely on subjective weighting, inconsistent criteria and simplified scoring systems that may not adequately reflect uncertainty. As a result, decision processes can become difficult to defend, challenging to audit and prone to internal debate.
This webinar will present a novel structured decision-support tool that replaces arbitrary scoring with transparent, repeatable comparisons. The tool organizes available evidence, supports consistent evaluation across alternatives and generates outputs with a clear and auditable rationale. Rather than compressing uncertainty into a single composite score, the tool makes underlying assumptions and evidence drivers explicit, enabling stakeholders to understand what influences a ranking and what conditions could alter an outcome.
Attendees will learn how structured decision environments can support cross-functional alignment, improve confidence in portfolio and trial strategy decisions and strengthen governance without requiring extensive system changes. Practical use cases will be discussed, including portfolio prioritization, target selection, biomarker strategy and clinical trial optimization.
Register for this webinar to learn how a decision-support tool can strengthen defensibility, transparency and consistency in biopharma decision-making.
Join Juan Felipe Beltrán Lacouture, PhD, Senior Director of AI, Machine Learning & Innovation, BullFrog AI, for the live webinar on Friday, March 27, 2026, at 11am EST (4pm CET/EU-Central).
For more information, or to register for this event, visit Turning AI Recommendations into Clear, Defensible Decisions.
Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us
Contact:Vera KovacevicTel: +1 (416) 977-6555 x371Email: [email protected]
SOURCE Xtalks
Share this article